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Umbilical serum tumor necrosis factor-a and
interleukin-6 in chorioamnionitis
Abstract
Background and Purpose: The term chorioamnionitis describes both
clinical symptoms of intrauterine infection and antenatal inflammatory
processes in the placental tissue. We studied umbilical serum tumor necrosis
factor-a (TNF-a) and interleukin-6 (IL-6) content in clinical chorio-
amnionitis with/without histological inflammation and in histological
chorioamnionitis without clinical signs.
Materials and Methods: We examined amniotic and placental tissues
and umbilical cord blood samples (111) from 40 patients with clinical
chorioamnionitis and 71 without it. We stratified patients according to clin-
ical and histological findings. Umbilical serum concentrations of TNF-a
and IL-6 were determined with immunoassay. To estimate systemic in-
flammation in infants, we used cut off values >15 pg/mL for TNF-a and
>11 pg/mL for IL-6. To analyze the results, we applied methods of
nonparametric statistics.
Results: In clinical chorioamnionitis, median umbilical serum concen-
trations of TNF-a and IL-6 were elevated only when histological inflam-
mation (all P<0.001) was present. In histological chorioamnionitis with-
out clinical signs, median concentrations of TNF-a and IL-6 were also
elevated (P<0.001, <0.048). The percentage of elevated cytokines was
higher in chorioamnionitis with than without placental inflammation.
Cytokine patterns were different in chorioamnionitis patients and controls.
Conclusion: Associated clinical and histological chorioamnionitis and
histological chorioamnionitis enhanced inflammatory cytokine concentra-
tions and the percentage of elevated cytokine values. The contribution of
clinical chorioamnionitis without placental inflammation to umbilical se-
rum cytokine content was minor.
INTRODUCTION
The term chorioamnionitis describes a clinical symptom complexsuggestive of intrauterine infection that may include some combi-
nation of maternal fever, membrane rupture (1), elevated white blood
cell count, abdominal pain and foul smelling vaginal discharge (2).
The term chorioamnionitis also describes antenatal inflammatory pro-
cesses in placental tissue with specific histological features, often asso-
ciated with preterm birth, preterm premature fetal membrane rupture,
increased risk of neonatal sepsis and death (3). However, placental tis-
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symptom complex known as chorioamnionitis (1, 4),
while almost three-fourths of the cases with histological
evidence of inflammation are clinically silent (5). Sever-
ity and duration of intra-uterine inflammation and its
possible spread to the fetus are critical for the clinical out-
come of infant (6). Many authors have detected elevated
umbilical cord inflammatory cytokines in chorioamnio-
nitis (6), yet the particular contribution of histological or
clinical inflammation to cytokine elevation remains un-
clear. In histological chorioamnionitis, elevated umbili-
cal serum TNF-a and IL-6 (7) were observed, together
with elevated TNF-a (8), raised IL-6 with stable TNF-a
concentrations (9) and elevated IL-6 (10-12). In clinical
chorioamnionitis, elevated IL-6 was found frequently,
while TNF-a was detected less often (13-16). We con-
ducted the present study to investigate the contribution
of clinical and histological chorioamnionitis to elevated
umbilical serum TNF-a and IL-6 content, and frequen-
cy of elevated cytokine values in chorioamnionitis.
PATIENTS AND METHODS
The study examined a cohort of 111 singleton preg-
nant women admitted for delivery at the University Hos-
pital Sisters of Mercy during the period of October 2002
to June 2003. Clinical chorioamnionitis was diagnosed
in 40 patients in the presence of maternal temperature
higher than 38.0 °C, premature rupture of membranes
and premature birth (1), plus two or more of the follow-
ing criteria: fetal tachycardia (>160 beats/min), maternal
tachycardia, uterine tenderness, foul-smelling amniotic
fluid, leucocytosis (>15x109 leukocyte/L, non-segment-
ed leucocytes >15 %) or elevated C-reactive protein (2,
17). Chorioamnionitis patients with gestational age of
32-38 weeks were included. Seventy-one consecutive pa-
tients without signs of genital or extra genital infection,
spontaneous contractions at term, normal labor duration
and absence of major malformations were included. We
collected chorioamnion and placental tissues and neona-
tal umbilical cord blood (111) after delivery.
The Regional Committee for Ethics in Medical Re-
search approved the study. We obtained informed con-
sent from all the participating women.
A pathologist blinded to the clinical conditions of
mothers and infants detected histological chorioamnio-
nitis using the described criteria (11). All placentas were
examined within 24 h of collection. Placental tissues,
with attached fetal membranes, were immersed in 4%
formaldehide immediately after delivery. After fixation,
eight tissue samples were processed. Two full-thickness
sections of the central placenta were taken within 5 cm
from the insertion of the umbilical cord. Another two
full-thickness sections of the periphery of the placenta
were prepared. Three transverse sections of the umbilical
cord taken at 5, 10 and 15 cm from the insertion and em-
bedded into one block, and one standard membrane roll
including the lining against the placenta were prepared.
One 5 mm section from each block was stained with
hematoxylin, erythosin and saffron and examined mi-
croscopically. The presence of polymorphonuclear leu-
kocytes was separately assessed in the free membranes
(amnion and chorion-decidua), in the chorionic plate,
and in the umbilical cord. Ten or more polymorpho-
nuclear leukocytes per high-power field (18) in any tis-
sue qualified as positive for chorioamnionitis (3).
Patients were stratified according to clinical and histo-
logical findings into groups: clinical without histological
chorioamnionitis, histological without clinical chorio-
amnionitis, associated clinical with histological chorio-
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TABLE 1
Clinical and histological findings for the study population.























Weeks 39.7±1.2 35.2±3.2 0.030
Preterm premature membrane










*Number of positive (% positive)
amnionitis and neither clinical nor histological chorio-
amnionitis (controls). Cut-off plasma concentrations to
define the fetal inflammatory response had previously
been defined as >15 pg/mL (19) for TNF-a, and >11
pg/mL for IL-6 (12, 17).
Umbilical serum samples (111), prepared from 2 mL
of cord blood collected at birth, were run immediately by
an automated chemiluminescence assay (EURO/DPC-
Diagnostic Immulite Products Corporation, Gwynedd
LL55 4EL, United Kingdom). Analytical sensitivity was
1.7 pg/mL for TNF-a and 2.0 pg/mL for IL-6.
STATISTICAL ANALYSIS
We expressed results as the median and a 5-95 % per-
centile range. Statistical differences among groups were
determined using the Kruskal-Wallis test, and the Mann-
Whitney U tests to detect pair differences. Proportions
were compared by the chi-square test. Computation was
performed using Medcalc statistical software 7.3.0.0. for
Windows (Medcalc Inc., Mariakerke, Belgium).
RESULTS
We presented characteristics of the population studied
in Table 1 and median umbilical serum TNF-a and IL-6
concentrations in Table 2. In clinical chorioamnionitis,
TNF-a and IL-6 concentrations were elevated only if
histological inflammation was present (all P<0.001). In
histological chorioamnionitis without clinical signs,
TNF-a and IL-6 concentrations were also elevated
(P<0.001, <0.048). Frequency of elevated cytokine val-
ues in chorioamnionitis patients was calculated and pre-
sented in Fig 1. In infants not previously exposed to
histological or clinical chorioamnionitis, the percent of
elevated TNF-a or IL-6 values was low. In
chorioamnionitis patients, the percent of elevated
TNF-a or IL-6 was higher and cytokine pattern was dif-
ferent compared to controls. In chorioamnionitis pa-
tients, besides elevated TNF-a or IL-6 values, concur-
rently elevated both cytokines were present. Frequency of
concurrently elevated TNF-a and IL-6 was higher in
chorioamnionitis with histological inflammation, e.g. in
associated clinical and histological chorioamnionitis and
in histological chorioamnionitis compared to clinical
chorioamnionitis.
DISCUSSION
Median umbilical serum cytokine content was high in
chorioamnionitis with placental inflammation, e.g. in
associated clinical and histological chorioamnionitis and
in histological chorioamnionitis without clinical signs.
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TABLE 2


































































Figure 1. Percent of elevated cytokine values (cut offs: 15pg/mL for
TNF-a, and >11 pg/mL for IL-6) in histological (HCA), clinical
(CCA) and associated clinical and histological (CCA+HCA) cho-
rioamnionitis.
TNF-a IL-6 TNF-a +IL-6
A vs B<0.01 A vs B<0.01 A vs B<0.01
A vs C NS A vs C<0.01 A vs C<0.01
A vs D<0.01 A vs D<0.01 A vs D<0.01
B vs C<0.01 B vs C NS B vs C NS
B vs D<0.01 B vs D<0.01 B vs D<0.01
C vs D<0.01 C vs D<0.01 C vs D<0.01
In the presence of placental inflammation, cytokines
were elevated in significant percent of chorioamnionitis
patients. Cytokine patterns were different in chorioamnio-
nitis patients and controls. Gestational age additionally
elevated umbilical serum IL-6 content. Preterm histo-
logical chorioamnionitis patients had higher IL-6 con-
tent than term patients did.
Similar umbilical serum TNF-a and IL-6 concentra-
tions in histological chorioamnionitis patients were shown
before (7). Different patterns of TNF-a and IL-6, de-
scribed here for term and preterm histological chorio-
amnionitis, are comparable to a recent experimental study
(20). After perfusion of term and preterm placental tissue
with endotoxin, different concentrations of TNF-a and
IL-6 were detected. While term and preterm placental
tissue produced similar amounts of TNF-a, preterm tis-
sue produced more IL-6 compared to term tissue. Cyto-
kine patterns noted in perfusates and in umbilical serums
of histological chorioamnionitis patients were similar.
These results suggested placental origin of umbilical se-
rum cytokines in histological chorioamnionitis, thus sup-
porting some earlier idea (7, 11, 14). The study of cyto-
kine transfer across placenta reinforced this approach.
Cytokines are transferred across inflamed, but not across
non-uninflamed placentas (20, 21). Concurrently ele-
vated TNF-a and IL-6, shown here in umbilical sera of
chorioamnionitis patients, were described earlier for sep-
tic infants (22). The combination of elevated values of
TNF-a and IL-6 was a good predictor of neonatal sepsis.
Possible clinical value of concurrently elevated TNF-a
and IL-6 in chorioamnionitis patients requires some fur-
ther investigation. Cytokine quantification by immuno-
assays is rapid, sensitive, specific and easy to perform.
The absence of TNF-a in histological chorioamnio-
nitis (9) and in clinical chorioamnionitis (16) where pla-
cental tissue inflammation is present in about two thirds
of patients (1, 4) is difficult to explain. Inflammatory
cytokines IL-1 and TNF-a act at the beginning of in-
flammatory cascade to initiate and propagate the process
(23, 24). We could speculate that some environmental
factors or type of pathogen (25) could interfere with
cytokine mechanisms leading to substitution of TNF-a
with IL-1 in some cytokine networks.
Previous study of clinical and histological chorioam-
nionitis in terms of inflammatory cytokines showed sig-
nificant variability (8-16). We demonstrated that clinical
chorioamnionitis with/without histological inflamma-
tion and histological chorioamnionitis exert distinct ef-
fects on cytokine content and therefore could contribute
to variability of cytokine results.
Cytokines are produced in inflammation, but as well
during parturition, maternal and fetal immune response
and hypoxic-ischemic injury (6). This explains the pres-
ence of elevated umbilical cytokines in infants not previ-
ously exposed to chorioamnionitis. If inflammatory cyto-
kines, produced abundantly at the inflammation sites,
spill over from a particular tissue to blood they will cause
fever, leukopenia, intravascular coagulation and shock
(26). Elevated concentrations of inflammatory cytoki-
nes, if not properly down-regulated, can damage
fetal/infant vital organs such as brain, lungs, and intes-
tine (6). The link between inflammatory response and
adverse infant outcome is now documented (6).
Our study details effects of clinical and histological
inflammation on umbilical serum inflammatory cyto-
kine content. We confirmed significant enhancing effect
of histological inflammation on umbilical serum cyto-
kine content known before, but also noted that even in
the presence of histological chorioamnionitis some in-
fants had low (normal) umbilical serum inflammatory
cytokine content. These results suggest that placental in-
flammation does not always spread to the fetus. We ex-
pect that low umbilical serum cytokine content in cho-
rioamnionitis patients will be associated with normal
fetal development during and after chorioamnionitis,
while the candidates with high risk for adverse outcome
are among patients with high umbilical serum cytokines.
Conclusion: Associated clinical and histological cho-
rioamnionitis and histological chorioamnionitis enhanc-
ed inflammatory cytokine concentrations and percent of
elevated cytokine values. The effect of clinical chorio-
amnionitis without placental inflammation on umbilical
serum cytokine content was minor.
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